US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Articles published by Revvity

< Previous 1 2 3 Next >
News headline image
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Host Investor Day
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Hold Earnings Call on November 3, 2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
From Revvity
Via Business Wire
News headline image
Revvity Announces Financial Results for the Second Quarter of 2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical Labs
From Revvity
Via Business Wire
News headline image
Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day One
From Revvity
Via Business Wire
News headline image
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Hold Earnings Call on Tuesday, August 4, 2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
From Revvity
Via Business Wire
News headline image
Revvity Announces Financial Results for the First Quarter of 2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026
From Revvity
Via Business Wire
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Hold Earnings Call on Tuesday, May 5, 2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
From Revvity
Via Business Wire
Tickers RVTY
News headline image
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire
Tickers RVTY
< Previous 1 2 3 Next >